Skip to main content
Radiopharm Theranostics Ltd logo

Radiopharm Theranostics Ltd — Investor Relations & Filings

Ticker · RADX ISIN · US75041J1016 US Professional, scientific and technical activities
Filings indexed 110 across all filing types
Latest filing 2026-04-23 Foreign Filer Report
Country US United States of America
Listing US RADX

About Radiopharm Theranostics Ltd

https://radiopharmtheranostics.com/

Radiopharm Theranostics is a clinical-stage radiotherapeutics company developing a pipeline of products for both the diagnosis and treatment of cancer. The company focuses on creating first-in-class radiopharmaceuticals that address significant unmet needs in oncology. Its development strategy leverages a diverse range of proprietary platforms, including antibodies, nanobodies, peptides, and small molecules, to target novel cancer pathways. By avoiding common industry targets, the company aims to develop differentiated and precise therapies to improve patient outcomes.

Recent filings

Filing Released Lang Actions
6-K - Radiopharm Theranostics Ltd (0001949257) (Filer)
Foreign Filer Report
2026-04-23 English
6-K - Radiopharm Theranostics Ltd (0001949257) (Filer)
Foreign Filer Report
2026-04-20 English
6-K - Radiopharm Theranostics Ltd (0001949257) (Filer)
Foreign Filer Report
2026-04-16 English
6-K - Radiopharm Theranostics Ltd (0001949257) (Filer)
Foreign Filer Report
2026-04-08 English
6-K - Radiopharm Theranostics Ltd (0001949257) (Filer)
Foreign Filer Report
2026-04-07 English
6-K - Radiopharm Theranostics Ltd (0001949257) (Filer)
Foreign Filer Report
2026-03-24 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.